AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

Airsculpt Technologies, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$1.25−0.03 (-2.35%)

Close on Oct 19, 2026

Market cap: $88.13M
P/E (TTM): –
Dividend yield: –

Airsculpt Technologies, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	152	180	196	169	133	63	41
Cost of Revenue	62	71	74	63	45	23	15
Gross Profit	90	109	122	106	89	39	26
Selling, General & Admin	82	99	102	101	66	24	20
Advertising Expenses	27	33	26	21	15	7.00	7.20
Total Costs & Expenses	163	182	186	173	118	53	41
Operating Income	-12	-1.58	9.72	-4.55	16	10	0.66
Interest Expense	6.08	6.25	6.49	6.75	4.89	2.46	2.88
Asset Impairment Charges	6.70	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	-4.58	-0.02	0.21	-0.15	0	0	–
Pretax Income	-18	-7.83	3.24	-11	11	7.58	-2.21
Income Tax Expense	-5.97	0.19	7.48	3.38	0.33	0	0
Net Income	-12	-8.02	-4.24	-15	11	7.58	-2.21
Net Income to Common	-12	-8.02	-4.24	-15	11	–	–
EPS (Basic)(per share)	-0.19	-0.14	-0.08	-0.26	-0.01	–	–
EPS (Diluted)(per share)	-0.19	-0.14	-0.08	-0.26	-0.01	–	–
Shares Outstanding (Basic, Weighted)(shares)	60	58	57	56	56	–	–
Shares Outstanding (Diluted, Weighted)(shares)	60	58	57	56	56	–	–
Dividend per Share(per share)	–	–	–	0.41	–	–	–
EBITDA	1.22	10	20	3.52	22	16	5.62

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.7%
Operating margin: -8.4%
Net margin: -7.8%
Return on equity, FY2025: -14.1%

Financial strength

Current ratio: 0.79
Debt to equity: 0.42
Debt to assets: 22.5%
Cash to current liabilities: 53.9%

Valuation

P/E ratio: –
Price to sales: 0.58
Price to book: 0.84
Dividend yield: –